Personalized medicine does not immediately fit into the generic industry model of high-volume and low prices, given its goal of providing tailored treatments for a single patient. Still, Association for Accessible Medicines president and CEO Dan Leonard wants the industry to consider its options.
During his 27 May State of AAM address as part of the generics trade association’s annual meeting, Leonard announced the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?